{
    "nctId": "NCT02311647",
    "briefTitle": "Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients",
    "officialTitle": "Uterine Cavity Assessment and Endometrial Gene Expression in Tamoxifen Treated Breast Cancer Patients",
    "overallStatus": "UNKNOWN",
    "conditions": "Endometrial Receptivity Post Tamoxifen Exposure",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 120,
    "primaryOutcomeMeasure": "Endometrial cells gene expression post Tamoxifen exposure",
    "eligibilityCriteria": "Inclusion Criteria:\n\nBreast cancer patients who are:\n\n* \\< 45 years\n* premenopausal\n* Had no previous uterine operations (previous D\\&C is allowed)\n* Currently receiving or having received Tamoxifen for at least 1 year.\n\nExclusion Criteria:\n\n* None",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT"
}